Telix Pharmaceuticals Limited (ASX:TLX) is a global, commercial-stage biopharmaceutical company headquartered in Melbourne, Australia. The company specialises in developing and commercialising diagnostic and therapeutic radiopharmaceuticals, focusing on oncology and rare diseases. Telix’s product portfolio includes imaging agents and targeted therapies that utilise molecularly targeted radiation to address significant unmet medical needs. Telix is also advancing […]